HIT
Health In Tech, Inc.
NASDAQ · Technology · Software - Application · US
$0.64
−2.58%Year over year
Reported trailing growth
- Revenue
- +23.0%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +20.0%
- EBITDA
- -39.3%
- EPS
- -65.5%
Three-year CAGR
- Revenue
- +79.4%
- EBITDA
- +132.2%
- EBIT
- +95.2%
- Net income
- +152.2%
- EPS
- +137.1%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026